Open AccessIntroduction of the Pelleted Smallpox Vaccine TEOVak into Serial Production to Provide Biosafety of the Population of the Russian Federation
Author(s) -
В. П. Бондарев,
А. И. Терентьев,
С. А. Мельников,
Т. А. Бондарева
Publication year - 2010
Publication title -
problemy osobo opasnyh infekcij
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.16
H-Index - 3
eISSN - 2658-719X
pISSN - 0370-1069
DOI - 10.21055/0370-1069-2010-2(104)-66-68
Subject(s) - biosafety , smallpox , certification , documentation , russian federation , population , quality (philosophy) , conformity assessment , virology , engineering , medicine , computer science , business , environmental health , operations management , microbiology and biotechnology , vaccination , biology , political science , law , philosophy , epistemology , programming language , economic policy
The industrial basis was developed and licensed to produce effective pelleted oral smallpox vaccine TEOVak in the Virologic Centre. Several series of TEOVak preparation were produced in accordance with the industrial technology on a built-in processing line consisting of blocks and modules. Certification and evaluation of preparation's quality indices in the process of storage were carried out. Results of the evaluation proved the conformity of vaccine's characteristics with the requirements of the normative technologic documentation.